Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:approvalYear |
1960
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N05BA12
|
| gptkbp:CASNumber |
50-49-7
|
| gptkbp:discoveredBy |
gptkb:Leo_Sternbach
|
| gptkbp:drugClass |
benzodiazepine
|
| gptkbp:eliminationHalfLife |
5-30 hours
|
| gptkbp:hasMolecularFormula |
C15H11ClN2
|
| https://www.w3.org/2000/01/rdf-schema#label |
D07917
|
| gptkbp:metabolism |
liver
|
| gptkbp:PubChem_CID |
DB00316
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous |
| gptkbp:sideEffect |
confusion
drowsiness ataxia |
| gptkbp:synonym |
gptkb:Chlordiazepoxide
|
| gptkbp:usedFor |
anxiety
sedation alcohol withdrawal |
| gptkbp:bfsParent |
gptkb:Invanz
|
| gptkbp:bfsLayer |
5
|